Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infliximab”

413 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 413 results

Testing effectiveness (Phase 2)Study completedNCT02363738
What this trial is testing

12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression

Who this might be right for
Bipolar Depression
University Health Network, Toronto 60
Post-approval studies (Phase 4)Study completedNCT00936143
What this trial is testing

Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis

Who this might be right for
Spondylitis
Gu Jieruo 70
Large-scale testing (Phase 3)WithdrawnNCT04535518
What this trial is testing

Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease

Who this might be right for
Kawasaki Disease
Children's Hospital of Fudan University
Post-approval studies (Phase 4)Study completedNCT02148640
What this trial is testing

The NOR-SWITCH Study

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis+3 more
Diakonhjemmet Hospital 482
Large-scale testing (Phase 3)Study completedNCT00254982
What this trial is testing

Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 593
Large-scale testing (Phase 3)Study completedNCT00251641
What this trial is testing

The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 868
Large-scale testing (Phase 3)Ended earlyNCT01190839
What this trial is testing

Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

Who this might be right for
Crohn's Disease
Janssen Biotech, Inc. 297
Not applicableStudy completedNCT05796245
What this trial is testing

Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

Who this might be right for
Arthritis, RheumatoidColitis, UlcerativeCrohn Disease+1 more
Pfizer 2,207
Testing effectiveness (Phase 2)WithdrawnNCT01846026
What this trial is testing

Ulcerative Colitis and Vitamin D Supplementation

Who this might be right for
Ulcerative Colitis
University Hospital of North Norway
Large-scale testing (Phase 3)Study completedNCT01004432
What this trial is testing

Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

Who this might be right for
ArthritisArthritis, RheumatoidAutoimmune Diseases
Janssen Biotech, Inc. 433
Large-scale testing (Phase 3)Study completedNCT03704363
What this trial is testing

BackToBasic: Infliximab in Chronic Low Back Pain and Modic Changes

Who this might be right for
Low Back Pain
Oslo University Hospital 128
Large-scale testing (Phase 3)Ended earlyNCT04974099
What this trial is testing

Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease

Who this might be right for
Crohn Disease
Children's Hospital Medical Center, Cincinnati 6
Large-scale testing (Phase 3)Study completedNCT00336492
What this trial is testing

The Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Centocor, Inc. 60
Not applicableStudy completedNCT02728934
What this trial is testing

Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Janssen Scientific Affairs, LLC 1,279
Post-approval studies (Phase 4)Study completedNCT02770794
What this trial is testing

Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Chiba University 211
Large-scale testing (Phase 3)Ended earlyNCT00307931
What this trial is testing

Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab

Who this might be right for
Crohn's Disease
UCB Pharma 16
Not applicableStudy completedNCT01233583
What this trial is testing

Regulatory T-cells in Psoriasis Patients as Targets for Therapy

Who this might be right for
Psoriasis
University of Aberdeen 38
Not applicableStudy completedNCT06269185
What this trial is testing

Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis

Who this might be right for
Ulcerative ColitisInflammatory Bowel Diseases
Vastra Gotaland Region 271
Testing effectiveness (Phase 2)Ended earlyNCT00076726
What this trial is testing

The Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis

Who this might be right for
Giant Cell Arteritis
Centocor, Inc. 44
Large-scale testing (Phase 3)WithdrawnNCT03088293
What this trial is testing

Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)

Who this might be right for
Idiopathic Refractory Scleritis
Hospices Civils de Lyon
Load More Results